Viewing nowCombinationJelostar Tablets 20/10 mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Hankook Hyutecs Pharmaceutical Co., Ltd.

MFDS item code 202003966 · Approved 2020.05.28 · Insurance code 649104890
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerotic progression and cardiovascular disease risk
This medication contains two components, Olmesartan Medoxomil and Rosuvastatin, and is used for patients who need to manage both hypertension and dyslipidemia simultaneously. Olmesartan Medoxomil helps treat essential hypertension, which is hypertension without an identifiable cause. Meanwhile, Rosuvastatin improves lipid disorders such as hypercholesterolemia and is used as an adjunct when management through diet and exercise alone is insufficient. This ingredient plays a significant role in slowing the progression of atherosclerosis and reducing the risk of cardiovascular diseases. It is particularly effective in reducing the risk of recurrence after strokes, myocardial infarction, and arterial revascularization procedures. Therefore, this medication is used to improve the condition of patients with both hypertension and hyperlipidemia.
This medicine is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each of the active ingredients, olmesartan medoxomil and rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood-pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum at about 8 weeks. If blood pressure is not controlled with this medicine alone, it may be given in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. 2. Elderly patients No dose adjustment is needed when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is needed for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended. ◆ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 2. Elderly patients No dose adjustment is needed. 3. Patients with renal impairment No dose adjustment is needed for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking olmesartan medoxomil and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.
Children under 18 years of age: Safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication or its ingredients, pregnant women, women who may become pregnant, and breastfeeding women should not take it. Use is contraindicated in patients with significantly impaired kidney function, those undergoing kidney dialysis, those with severe liver disease, and those with biliary obstruction, among other specific health conditions. Patients with muscle diseases or a history of muscle-related side effects, as well as those taking certain medications, are also advised against using this medication. Caution is required in patients with low blood volume or salt, as hypotension may occur, and regular monitoring of kidney function is necessary as changes may occur. Due to the risk of hyperkalemia, blood potassium levels should be checked frequently, and patients with cardiovascular diseases should also exercise caution. This medication may affect liver function, so liver function tests are recommended before and during treatment. If symptoms of muscle pain or weakness occur, inform medical personnel immediately, and in severe cases, medication may need to be stopped. Dizziness may occur, so it is advisable to avoid driving or operating hazardous machinery. This medication can interact with other drugs, so it is essential to inform healthcare providers about any other medications being taken. Pregnant or breastfeeding women should not take this medication as it may pose risks to the fetus or newborn, and women of childbearing age should use appropriate contraception. Safety in children under 18 years has not been established, so use is not recommended in this age group. Elderly patients may have increased plasma concentrations of the drug, so dose adjustments and caution are necessary. In case of overdose, symptoms such as hypotension and palpitations may occur, requiring immediate medical treatment.
Increase in ALT, increase in AST, increase in blood creatinine, decreased creatinine clearance, headache, dizziness, sensory impairment, neuropathy, drowsiness, gastroesophageal reflux disease, constipation, dental caries, dyspepsia, gastric ulcer, gastritis, gastroenteritis, musculoskeletal stiffness, atrial fibrillation, hypoglycemia, chest pain, extraction, chest discomfort, peripheral edema, vertigo, abdominal pain, nausea, palpitations, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, facial edema, asthenia, vascular edema, anaphylactic reaction, vomiting, chronic malabsorption syndrome-like intestinal disease, intestinal vasogenic edema, rhabdomyolysis, hyperkalemia, acute renal failure, hair loss, pruritus, urticaria, autoimmune hepatitis, dizziness including orthostatic dizziness, headache, palpitations, increased blood pressure, low back pain, increased blood creatinine, diarrhea, pruritus, cough, epistaxis, upper respiratory infection, asthma, hypersensitivity reaction including vascular edema, diabetes, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy including myositis, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders including insomnia and nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe myasthenia, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect from air or moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius.
White or pale yellow round film-coated tablets
30 tablets/box [(10 tablets/Alu-Alu) x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Hankook Hyutecs Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.